Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease-Reference-Cited by-同舟云学术

Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease

Published:2008-08-01 Issue:8 Volume:118 Page:2796-2807
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Trinchese Fabrizio,Fa’ Mauro,Liu Shumin,Zhang Hong,Hidalgo Ariel,Schmidt Stephen D.,Yamaguchi Hisako,Yoshii Narihiko,Mathews Paul M.,Nixon Ralph A.,Arancio Ottavio

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference71 articles.

1. The calpain family and human disease

2. The calpains in aging and aging-related diseases

3. The ultrastructural localization of calcium-activated protease ?calpain? in rat brain

4. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration.

5. Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease

Cited by 181 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autophagy–lysosomal-associated neuronal death in neurodegenerative disease;Acta Neuropathologica;2024-09-11

2. Peroxiredoxin 1 inhibits streptozotocin-induced Alzheimer’s disease-like pathology in hippocampal neuronal cells via the blocking of Ca2+/Calpain/Cdk5-mediated mitochondrial fragmentation;Scientific Reports;2024-07-08

3. Calpain: An Emerging Therapeutic Target;Research Journal of Pharmacology and Pharmacodynamics;2024-02-29

4. Peroxiredoxin 1 inhibits streptozotocin-induced Alzheimer’s disease-like pathology in hippocampal neuronal cells via Ca 2+ /Calpain/Cdk5-mediated mitochondrial fragmentation;2024-01-29

5. Failure of more than 400 candidate medications in clinical trials before 2020;Alzheimer' s Disease Research Guide;2024